Medical World News
Medical World NewsTM Spring 2024 edition features information across the Medical World NewsTM Streaming Network programs, including Behind the ScienceTM, Wellbeing CheckupTM, Deep DiveTM, and more.
Volume: 1
Issue: 1
THIO Plus Cemiplimab Displays Efficacy in Checkpoint Inhibitor–Resistant NSCLC
CD47 Levels Are Prognostic of Response to Magrolimab Plus Docetaxel in Metastatic NSCLC
Frontline Vibostolimab/Pembrolizumab Plus Chemo Meets Futility Threshold in ES-SCLC
PD-L1, KIM-1 Expression Are Predictive of Outcomes With Adjuvant Nivolumab Alone, Plus Ipilimumab in ccRCC
